Earth Science Tech, Inc. (OTC: ETST) reported financial results for the fiscal year ended March 31, 2026, highlighting continued growth across its integrated healthcare platform. The company achieved revenue of $35.7 million, an 8% increase from the prior fiscal year, driven by expansion in telemedicine, pharmacy, and fulfillment services. Gross profit rose 5% to $25.5 million, while net income climbed 11% to $3.6 million. Total assets grew 27% year over year to $9.0 million, reflecting the company's strengthened balance sheet and investment in growth initiatives.
The company's capital allocation strategy remained a key focus, with management reporting the repurchase and retirement of more than 4 million shares during fiscal 2026 and over 7.1 million shares through fiscal 2026 and subsequent periods. This approach, combined with positive operating cash flow and a debt-free balance sheet, underscores the company's commitment to enhancing shareholder value while pursuing expansion. According to the press release, Earth Science Tech is entering fiscal 2027 with a focus on growth initiatives, product expansion, and continued share repurchases.
Earth Science Tech operates as a diversified holding company in the health and wellness sector, building a vertically integrated platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company's strategy integrates patient care from consultation to fulfillment through the synergy of its specialized subsidiaries, supported by investments in real estate and asset management. For more details, the full press release is available at https://ibn.fm/NpjTw.
The financial results reflect the company's ability to grow revenue and earnings while maintaining a strong balance sheet. The 8% revenue growth and 11% net income increase demonstrate operational efficiency and market demand for its integrated healthcare services. The company's focus on share repurchases signals confidence in its valuation and long-term prospects. As Earth Science Tech enters fiscal 2027, its emphasis on product expansion and growth initiatives positions it to capitalize on opportunities in the healthcare sector. Investors can find the latest news and updates on the company's newsroom at https://ibn.fm/ETST.
